Avian Influenza in Chickens: Kerala Outbreaks and Control

Etiology and Virology

Avian influenza (AI) is caused by infection with type A influenza viruses of the family Orthomyxoviridae. These viruses possess a segmented, single-stranded negative-sense RNA genome comprising eight segments. The viral envelope displays two major glycoproteins: hemagglutinin (HA) and neuraminidase (NA). To date, 16 HA subtypes (H1-H16) and 9 NA subtypes (N1-N9) have been identified in avian hosts, with additional subtypes H17N10 and H18N11 detected in bats [1]. The classification of AI viruses into low pathogenicity (LPAI) and high pathogenicity (HPAI) is based on the intravenous pathogenicity index (IVPI) in chickens and the presence of multiple basic amino acids at the HA cleavage site [2]. HPAI viruses, predominantly of subtypes H5 and H7, arise from LPAI precursors through the acquisition of a polybasic cleavage site, which permits systemic replication in poultry [3].

The molecular basis of pathogenicity resides in the HA0 cleavage site. LPAI viruses possess a monobasic cleavage site (e.g., -R-X-R/G-) that is cleaved only by trypsin-like proteases present in the respiratory and intestinal tracts. HPAI viruses contain a polybasic cleavage site (e.g., -R-X-R/K-R-R/G-) that is cleaved by ubiquitous furin-like proteases, enabling systemic dissemination [4]. The receptor-binding specificity of avian influenza viruses is directed toward alpha-2,3-linked sialic acid receptors, which predominate in the avian intestinal and respiratory epithelium [5]. This receptor tropism is a key determinant of host range and tissue distribution.

Epidemiology of Avian Influenza in Kerala

The state of Kerala, located in southwestern India, has experienced multiple outbreaks of HPAI in poultry, primarily involving the H5N1 subtype. The first confirmed outbreak in Kerala occurred in 2014 in the districts of Kottayam and Alappuzha, affecting commercial layer farms and backyard poultry [6]. Subsequent outbreaks were reported in 2016, 2020, and 2023, with the latter involving H5N1 clade 2.3.2.1c in the districts of Kollam, Pathanamthitta, and Alappuzha [7]. The epidemiological pattern in Kerala is characterized by seasonal peaks during the cooler months (November to February), coinciding with the migratory bird season [8].

The introduction of HPAI into Kerala is primarily attributed to the movement of infected wild waterfowl along the Central Asian Flyway. Kerala's extensive network of backwaters, wetlands, and paddy fields provides stopover sites for migratory birds, facilitating spillover into domestic poultry [9]. The state's poultry population, estimated at over 120 million birds, includes commercial layers, broilers, and backyard flocks, with the latter posing particular challenges for surveillance and biosecurity [10]. Risk factors for outbreak occurrence include proximity to wetlands, free-range management systems, and the movement of live birds through informal marketing channels [11].

Clinical Signs and Pathology

The clinical presentation of HPAI in chickens is acute and severe. The incubation period ranges from 24 to 48 hours, followed by sudden onset of high mortality, often reaching 100% within 72 hours [12]. Affected birds exhibit depression, ruffled feathers, inappetence, and a marked drop in egg production. Respiratory signs include dyspnea, coughing, sneezing, and serous to hemorrhagic nasal discharge. Neurological signs, including ataxia, torticollis, opisthotonos, and paralysis, are common due to viral invasion of the central nervous system [13]. Edema of the head, comb, and wattles, along with cyanosis, are characteristic findings. Hemorrhagic lesions may be observed on the comb, wattles, and shanks [14].

Postmortem examination reveals severe congestion and hemorrhage in multiple organs. The tracheal mucosa is hemorrhagic, and the lungs are edematous and congested. The spleen and kidneys are enlarged and congested. The pancreas may show necrotic foci. The most pathognomonic lesion is hemorrhagic pancreatitis, observed in a high proportion of cases [15]. The intestinal tract shows hemorrhagic enteritis, particularly in the cecal tonsils. The ovaries and oviducts in laying hens exhibit hemorrhage, regression, and yolk peritonitis. Histopathological examination reveals severe necrosis and inflammation in the heart, brain, and lymphoid tissues, with viral antigen detectable by immunohistochemistry [16].

Differential Diagnosis

The differential diagnosis for HPAI includes several acute viral and bacterial diseases of poultry. Newcastle disease (ND), caused by virulent strains of avian paramyxovirus type 1, presents with similar respiratory, neurological, and hemorrhagic signs. However, ND typically causes less pronounced edema of the head and wattles [17]. Infectious laryngotracheitis (ILT), caused by gallid alphaherpesvirus 1, produces severe respiratory distress and hemorrhagic tracheitis but lacks the systemic involvement and neurological signs of HPAI [18]. Fowl cholera, caused by Pasteurella multocida, can cause acute septicemia with high mortality but is characterized by fibrinous pericarditis and perihepatitis, which are not typical of HPAI [19]. Other conditions to consider include avian influenza in chickens caused by LPAI strains, which produce milder respiratory signs and drops in egg production without high mortality [20]. A comprehensive list of differentials is provided in the article Infectious Coryza in Poultry and Ducks.

Diagnostic Approaches

Rapid and accurate diagnosis is essential for outbreak control. The World Organisation for Animal Health (WOAH) recommends a combination of virus isolation, molecular detection, and serological testing [21].

Sample Collection and Submission

Samples should be collected from moribund or freshly dead birds. Oropharyngeal and cloacal swabs are placed in viral transport medium containing antibiotics. Tissues (trachea, lung, spleen, kidney, brain, and intestine) are collected for virus isolation and histopathology. Serum samples are collected for serological surveillance [22].

Virus Isolation

Virus isolation is performed by inoculating samples into the allantoic cavity of 9- to 11-day-old embryonated chicken eggs. Allantoic fluid is harvested after 48 to 72 hours and tested for hemagglutinating activity. The presence of influenza A virus is confirmed by agar gel immunodiffusion or enzyme-linked immunosorbent assay (ELISA) for the nucleoprotein [23].

Molecular Detection

Reverse transcription polymerase chain reaction (RT-PCR) targeting the matrix (M) gene is the primary molecular diagnostic method for influenza A virus detection. Real-time RT-PCR (rRT-PCR) provides quantitative results and is widely used for high-throughput screening [24]. Subtype-specific RT-PCR assays targeting the HA and NA genes are used to identify H5, H7, and N1 subtypes. The detection of the polybasic cleavage site by sequencing or melting curve analysis confirms HPAI status [25]. A detailed protocol is available in the article Polymerase Chain Reaction (PCR) for Avian Influenza Virus Detection.

Serological Testing

Serological surveillance is used for monitoring LPAI circulation and post-vaccination immunity. The hemagglutination inhibition (HI) test is the standard method for subtype-specific antibody detection. Commercial ELISA kits for detecting antibodies against the nucleoprotein are used for flock-level screening [26].

flowchart TD
    A[Clinical Suspicion of HPAI], > B[Sample Collection]
    B, > C[Oropharyngeal/Cloacal Swabs]
    B, > D[Tissue Samples]
    B, > E[Serum]
    C, > F[RNA Extraction]
    D, > F
    F, > G[rRT-PCR for M Gene]
    G, > H{Positive?}
    H, >|Yes| I[Subtype RT-PCR H5/H7]
    H, >|No| J[Report Negative]
    I, > K{Positive?}
    K, >|Yes| L[Cleavage Site Sequencing]
    K, >|No| M[Report LPAI or Other Subtype]
    L, > N{Polybasic Site?}
    N, >|Yes| O[Confirm HPAI]
    N, >|No| P[Report LPAI]
    O, > Q[Notify WOAH/State Authorities]
    Q, > R[Implement Stamping Out Protocol]

Control and Eradication Strategies

Control of HPAI in Kerala follows the national action plan for avian influenza, which is aligned with WOAH standards. The primary strategy is stamping out, which involves the culling of all poultry on infected premises and dangerous contact flocks [27].

Stamping Out and Depopulation

Upon laboratory confirmation of HPAI, an infected zone with a radius of 1 km and a surveillance zone with a radius of 10 km are established. All poultry within the infected zone are culled using methods approved for mass depopulation, such as whole-house gassing with carbon dioxide or foam-based systems [28]. Carcasses are disposed of by deep burial, incineration, or rendering. Strict movement controls are enforced within the surveillance zone, and all poultry premises are inspected clinically and serologically [29].

Biosecurity Measures

Biosecurity is the cornerstone of prevention. Key measures include the restriction of access to poultry houses, the use of dedicated footwear and clothing, and the implementation of boot dips and vehicle disinfection stations [30]. All-in/all-out management systems reduce the risk of pathogen carryover between flocks. Feed and water sources must be protected from contamination by wild birds. The separation of poultry from wild waterfowl is critical, particularly in wetland areas [31]. Comprehensive biosecurity protocols are discussed in the article Avian Influenza (HPAI) Spread: Transmission Pathways, Biosecurity, and Clinical Implications.

Vaccination

Vaccination is not routinely used in Kerala for HPAI control but may be considered as an adjunct to stamping out in high-risk areas or when the disease becomes enzootic. Inactivated whole-virus vaccines and recombinant vector vaccines (e.g., fowlpox virus expressing H5 HA) are available [32]. Vaccination requires a DIVA (Differentiating Infected from Vaccinated Animals) strategy, using sentinel birds or subunit vaccines that allow serological differentiation. The use of vaccination must be accompanied by enhanced surveillance to detect field virus circulation [33]. A detailed review of vaccine types and strategies is available in the article Avian Influenza Vaccine: Types, Strategies, and Efficacy in Poultry.

Surveillance and Early Detection

Passive surveillance relies on the reporting of increased mortality or clinical signs by poultry owners. Active surveillance involves regular sampling of poultry markets, live bird markets, and backyard flocks for virological and serological testing [34]. The use of molecular diagnostics for environmental samples, such as fecal swabs from wetlands, can provide early warning of virus introduction [35]. Data sharing through platforms such as the Global Initiative on Sharing All Influenza Data (GISAID) facilitates real-time monitoring of viral evolution and spread [36].

Public Health and One Health Considerations

While this article focuses on avian influenza in chickens, the zoonotic potential of HPAI H5N1 necessitates a One Health approach. Direct contact with infected poultry or contaminated environments is the primary route of human infection [37]. The control of AI in poultry is therefore a critical public health intervention. Coordination between veterinary and public health authorities is essential for outbreak response, risk communication, and the implementation of protective measures for cullers and veterinarians [38]. Further information on zoonotic aspects is provided in the article Avian Influenza in Chickens: Kerala Outbreaks and Zoonotic Potential.

Conclusion

Avian influenza remains a significant threat to the poultry industry in Kerala. The state's geographical location, wetland ecosystems, and poultry production systems create a high-risk environment for HPAI introduction and spread. Effective control requires rapid diagnosis, strict biosecurity, and coordinated stamping out operations. Ongoing surveillance, both passive and active, is essential for early detection. The integration of molecular diagnostics and genomic surveillance into routine veterinary practice will enhance the capacity to respond to emerging threats. Continued investment in biosecurity infrastructure and farmer education is critical for long-term disease prevention.

References

[1] Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56(1):152-179.

[2] World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.3.4: Avian influenza (including infection with high pathogenicity avian influenza viruses). Paris: WOAH.

[3] Swayne DE, Suarez DL. Highly pathogenic avian influenza. Rev Sci Tech. 2000;19(2):463-482.

[4] Steinhauer DA. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology. 1999;258(1):1-20.

[5] Gambaryan AS, Tuzikov AB, Bovin NV, et al. Differences between influenza virus receptors on target cells of duck and chicken. Arch Virol. 2002;147(6):1197-1208.

[6] Government of India, Department of Animal Husbandry, Dairying and Fisheries. Action Plan for Prevention, Control and Containment of Avian Influenza. New Delhi: Ministry of Agriculture.

[7] World Organisation for Animal Health (WOAH). Immediate notifications and follow-up reports: Highly pathogenic avian influenza, India. Paris: WOAH.

[8] Olsen B, Munster VJ, Wallensten A, Waldenstrom J, Osterhaus AD, Fouchier RA. Global patterns of influenza A virus in wild birds. Science. 2006;312(5772):384-388.

[9] Alexander DJ. An overview of the epidemiology of avian influenza. Vaccine. 2007;25(30):5637-5644.

[10] Government of Kerala, Department of Animal Husbandry. Poultry Census and Disease Surveillance Reports. Thiruvananthapuram: Government Press.

[11] Biswas PK, Christensen JP, Ahmed SS, et al. Risk factors for infection with highly pathogenic influenza A virus (H5N1) in commercial chicken farms in Bangladesh. Vet Rec. 2008;163(24):717-722.

[12] Swayne DE, Glisson JR, McDougald LR, Nolan LK, Suarez DL, Nair V, editors. Diseases of Poultry. 14th ed. Ames: Wiley-Blackwell.

[13] Perkins LE, Swayne DE. Pathobiology of A/chicken/Hong Kong/220/97 (H5N1) avian influenza virus in seven gallinaceous species. Vet Pathol. 2001;38(2):149-164.

[14] Mo IP, Brugh M, Fletcher OJ, Rowland GN, Swayne DE. Comparative pathology of chickens experimentally inoculated with avian influenza viruses of low and high pathogenicity. Avian Dis. 1997;41(1):125-136.

[15] Swayne DE. Understanding the complex pathobiology of high pathogenicity avian influenza viruses in birds. Avian Dis. 2007;51(1 Suppl):242-249.

[16] Pantin-Jackwood MJ, Swayne DE. Pathogenesis and pathobiology of avian influenza virus infection in birds. Rev Sci Tech. 2009;28(1):113-136.

[17] Alexander DJ. Newcastle disease and other avian paramyxoviruses. Rev Sci Tech. 2000;19(2):443-462.

[18] Bagust TJ, Jones RC, Guy JS. Avian infectious laryngotracheitis. Rev Sci Tech. 2000;19(2):483-492.

[19] Glisson JR, Hofacre CL, Christensen JP. Fowl cholera. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Ames: Wiley-Blackwell; 2020. p. 807-823.

[20] Spackman E, Swayne DE. Low pathogenicity avian influenza. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Ames: Wiley-Blackwell; 2020. p. 281-302.

[21] World Organisation for Animal Health (WOAH). Terrestrial Animal Health Code. Chapter 10.4: Infection with high pathogenicity avian influenza viruses. Paris: WOAH.

[22] Spackman E, Senne DA, Myers TJ, et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol. 2002;40(9):3256-3260.

[23] Swayne DE, Senne DA, Beard CW. Avian influenza. In: Swayne DE, editor. A Laboratory Manual for the Isolation, Identification and Characterization of Avian Pathogens. 5th ed. Athens: American Association of Avian Pathologists; 2008. p. 128-134.

[24] Spackman E, Suarez DL. Type A influenza virus detection and quantitation by real-time RT-PCR. Methods Mol Biol. 2008;436:19-26.

[25] Slomka MJ, Pavlidis T, Banks J, et al. Validated H5 Eurasian real-time reverse transcriptase-polymerase chain reaction and its application in H5N1 outbreaks in 2005-2006. Avian Dis. 2007;51(1 Suppl):373-377.

[26] Brown JD, Stallknecht DE, Berghaus RD, Swayne DE. Infectious and lethal doses of H5N1 highly pathogenic avian influenza virus for house sparrows (Passer domesticus) and rock pigeons (Columba livia). J Vet Diagn Invest. 2009;21(4):437-445.

[27] Capua I, Alexander DJ. Avian influenza: recent developments. Avian Pathol. 2004;33(4):393-404.

[28] Swayne DE, Spackman E. Current status and future needs in diagnostics and vaccines for high pathogenicity avian influenza. Dev Biol (Basel). 2013;135:79-94.

[29] Sims LD, Domenech J, Benigno C, et al. Origin and evolution of highly pathogenic H5N1 avian influenza in Asia. Vet Rec. 2005;157(6):159-164.

[30] Van Steenwinkel S, Ribbens S, Ducheyne E, Goossens E, Dewulf J. Assessing biosecurity practices, movements and densities of poultry sites across Belgium, resulting in different farm risk-groups for infectious disease introduction and spread. Prev Vet Med. 2011;98(4):259-270.

[31] Koch G, Elbers AR. Outdoor ranging of poultry: a major risk factor for the introduction and spread of highly pathogenic avian influenza virus. Neth J Agric Sci. 2006;54(2):179-194.

[32] Swayne DE, Kapczynski DR. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev. 2008;225:314-331.

[33] Suarez DL. Overview of avian influenza DIVA test strategies. Biologicals. 2005;33(4):221-226.

[34] Hinshaw VS, Webster RG, Turner B. The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl. Can J Microbiol. 1980;26(5):622-629.

[35] Stallknecht DE, Shane SM. Host range of avian influenza virus in free-living birds. Vet Res Commun. 1988;12(2-3):125-141.

[36] Shu Y, McCauley J. GISAID: Global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 2017;22(13):30494.

[37] World Health Organization (WHO). Avian influenza: assessing the pandemic threat. Geneva: WHO; 2005.

[38] Capua I, Alexander DJ. The challenge of avian influenza to the veterinary community. Avian Pathol. 2006;35(3):189-205. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.